Nifty
:
23587.50
Sensex
:
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)
Nifty
Sensex
:
:
23587.50
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)

Astec Lifesciences Ltd.

Pesticides & Agrochemicals

Rating :
N/A

BSE: 533138 | NSE: ASTEC

NSE BSE
1080.15
20-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  1082.00
  •  1085.95
  •  1079.05
  •  1081.85
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  8049
  •  86.97
  •  1474.40
  •  825.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,116.07
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,614.46
  • N/A
  • 7.26

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 66.75%
  • 3.47%
  • 21.94%
  • FII
  • DII
  • Others
  • 0.53%
  • 4.00%
  • 3.31%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.55
  • -2.60
  • -12.18

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 35.53
  • 34.89
  • 37.27

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.03
  • 7.26
  • 7.37

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -325.83
  • -521.79
  • -886.00

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
98.55
110.79
-11.05%
69.37
142.85
-51.44%
153.75
126.97
21.09%
50.79
117.18
-56.66%
Expenses
118.28
114.21
3.56%
115.63
139.72
-17.24%
141.04
121.57
16.02%
69.13
105.06
-34.20%
EBITDA
-19.73
-3.42
-
-46.26
3.13
-
12.71
5.40
135.37%
-18.33
12.12
-
EBIDTM
-20.03%
-3.09%
-66.68%
2.19%
8.27%
4.25%
-36.09%
10.35%
Other Income
2.00
0.98
104.08%
0.92
1.71
-46.20%
2.05
2.58
-20.54%
0.91
3.79
-75.99%
Interest
9.33
5.99
55.76%
7.04
6.46
8.98%
6.67
6.40
4.22%
6.10
5.88
3.74%
Depreciation
11.47
9.16
25.22%
9.27
9.39
-1.28%
9.01
7.76
16.11%
8.70
8.80
-1.14%
PBT
-38.54
-17.60
-
-61.64
-11.01
-
-0.93
-6.18
-
-32.22
1.24
-
Tax
0.01
-4.18
-
-21.92
-2.82
-
0.04
-1.21
-
-7.89
0.39
-
PAT
-38.55
-13.42
-
-39.72
-8.19
-
-0.96
-4.97
-
-24.33
0.85
-
PATM
-39.12%
-12.11%
-57.25%
-5.73%
-0.63%
-3.92%
-47.89%
0.72%
EPS
-19.66
-6.85
-
-20.26
-4.18
-
-0.50
-2.54
-
-12.41
0.43
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
372.46
458.18
628.17
676.57
554.87
522.61
430.90
367.58
298.67
246.99
266.88
Net Sales Growth
-25.18%
-27.06%
-7.15%
21.93%
6.17%
21.28%
17.23%
23.07%
20.92%
-7.45%
 
Cost Of Goods Sold
302.46
319.28
401.24
386.81
342.05
338.53
279.49
235.05
179.94
160.93
178.74
Gross Profit
70.00
138.90
226.92
289.76
212.82
184.07
151.41
132.54
118.74
86.05
88.14
GP Margin
18.79%
30.32%
36.12%
42.83%
38.35%
35.22%
35.14%
36.06%
39.76%
34.84%
33.03%
Total Expenditure
444.08
464.09
551.91
522.49
443.42
437.43
354.43
298.79
236.27
215.43
212.77
Power & Fuel Cost
-
35.87
45.68
38.04
25.28
28.80
23.80
17.87
15.75
13.84
3.56
% Of Sales
-
7.83%
7.27%
5.62%
4.56%
5.51%
5.52%
4.86%
5.27%
5.60%
1.33%
Employee Cost
-
61.74
52.26
50.31
38.35
29.92
25.10
21.71
20.38
15.89
12.27
% Of Sales
-
13.48%
8.32%
7.44%
6.91%
5.73%
5.83%
5.91%
6.82%
6.43%
4.60%
Manufacturing Exp.
-
18.51
17.95
14.29
12.62
10.16
8.67
7.41
6.67
4.71
0.89
% Of Sales
-
4.04%
2.86%
2.11%
2.27%
1.94%
2.01%
2.02%
2.23%
1.91%
0.33%
General & Admin Exp.
-
15.65
16.77
11.80
9.95
11.27
7.87
8.92
7.86
9.60
9.03
% Of Sales
-
3.42%
2.67%
1.74%
1.79%
2.16%
1.83%
2.43%
2.63%
3.89%
3.38%
Selling & Distn. Exp.
-
2.63
7.51
10.83
6.30
5.58
3.87
5.40
2.91
3.97
5.37
% Of Sales
-
0.57%
1.20%
1.60%
1.14%
1.07%
0.90%
1.47%
0.97%
1.61%
2.01%
Miscellaneous Exp.
-
10.42
10.50
10.40
8.87
13.17
5.63
2.43
2.77
6.49
5.37
% Of Sales
-
2.27%
1.67%
1.54%
1.60%
2.52%
1.31%
0.66%
0.93%
2.63%
1.09%
EBITDA
-71.61
-5.91
76.26
154.08
111.45
85.18
76.47
68.79
62.40
31.56
54.11
EBITDA Margin
-19.23%
-1.29%
12.14%
22.77%
20.09%
16.30%
17.75%
18.71%
20.89%
12.78%
20.28%
Other Income
5.88
5.64
13.06
10.47
8.03
11.93
11.16
8.11
2.86
7.21
0.93
Interest
29.14
25.23
20.71
9.06
4.75
12.59
12.38
10.66
12.24
12.81
12.84
Depreciation
38.45
36.25
33.65
34.36
25.66
23.16
19.35
14.68
13.68
10.40
12.69
PBT
-133.33
-61.75
34.95
121.13
89.07
61.35
55.90
51.56
39.34
15.57
29.52
Tax
-29.76
-14.86
9.35
31.24
24.00
13.83
20.14
20.67
9.56
7.36
-2.20
Tax Rate
22.32%
24.06%
26.75%
25.79%
26.95%
22.54%
36.03%
37.10%
33.26%
59.26%
-17.49%
PAT
-103.56
-46.93
25.56
89.86
65.05
47.51
35.74
34.91
19.12
4.97
14.77
PAT before Minority Interest
-103.60
-46.89
25.59
89.88
65.07
47.53
35.77
35.04
19.18
5.07
14.78
Minority Interest
-0.04
-0.04
-0.03
-0.02
-0.02
-0.02
-0.03
-0.13
-0.06
-0.10
-0.01
PAT Margin
-27.80%
-10.24%
4.07%
13.28%
11.72%
9.09%
8.29%
9.50%
6.40%
2.01%
5.53%
PAT Growth
0.00%
-
-71.56%
38.14%
36.92%
32.93%
2.38%
82.58%
284.71%
-66.35%
 
EPS
-52.84
-23.94
13.04
45.85
33.19
24.24
18.23
17.81
9.76
2.54
7.54

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
369.29
419.36
396.50
309.18
246.57
202.49
169.65
138.02
118.03
135.34
Share Capital
19.61
19.61
19.60
19.59
19.57
19.55
19.53
19.51
19.46
19.46
Total Reserves
349.30
399.40
376.61
289.18
226.33
182.16
149.23
117.78
97.83
115.88
Non-Current Liabilities
208.29
33.69
38.14
45.99
6.46
9.48
4.86
1.70
6.47
48.94
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.25
0.40
8.18
12.72
Unsecured Loans
199.00
10.86
0.00
40.00
0.00
0.00
0.00
0.00
0.00
0.50
Long Term Provisions
0.48
0.50
29.06
0.52
0.32
0.23
0.17
0.07
0.45
0.74
Current Liabilities
397.16
526.20
490.59
322.28
318.36
248.80
238.39
193.72
202.97
177.58
Trade Payables
89.28
177.18
189.83
128.18
202.39
63.25
99.93
57.07
68.00
87.84
Other Current Liabilities
23.56
62.99
60.96
46.43
16.72
9.52
13.84
10.16
25.04
7.64
Short Term Borrowings
282.96
285.28
239.37
147.03
98.71
175.67
124.17
126.00
108.57
77.38
Short Term Provisions
1.36
0.75
0.43
0.63
0.54
0.36
0.44
0.50
1.37
4.72
Total Liabilities
974.97
979.44
925.39
677.59
571.72
461.08
413.18
333.59
327.56
361.91
Net Block
385.96
318.47
339.94
212.68
193.62
166.95
115.07
102.94
94.67
133.06
Gross Block
592.35
488.05
477.12
315.53
270.99
221.36
150.15
124.45
105.04
201.03
Accumulated Depreciation
206.39
169.58
137.18
102.85
77.36
54.41
35.08
21.51
10.37
67.96
Non Current Assets
576.47
480.59
409.71
347.16
239.97
212.60
181.50
135.22
136.37
158.40
Capital Work in Progress
165.03
126.60
22.82
115.71
24.11
18.98
41.87
7.56
19.85
12.25
Non Current Investment
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
Long Term Loans & Adv.
25.47
35.51
46.94
18.76
22.23
26.67
24.56
21.56
18.05
13.06
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
3.16
3.80
0.00
Current Assets
398.49
498.85
515.68
330.43
331.75
248.48
231.68
198.37
191.19
203.51
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.09
Inventories
195.85
294.85
186.95
106.09
121.17
92.85
78.48
65.55
71.25
71.93
Sundry Debtors
169.00
154.90
273.63
187.15
160.84
121.81
123.15
110.66
80.61
103.63
Cash & Bank
2.43
2.16
2.13
1.57
1.49
1.48
1.50
4.23
6.05
12.02
Other Current Assets
31.21
5.37
9.85
4.22
48.25
32.34
28.56
17.93
33.27
15.84
Short Term Loans & Adv.
24.45
41.58
43.13
31.39
41.82
30.07
27.28
17.32
31.05
15.30
Net Current Assets
1.33
-27.35
25.09
8.15
13.39
-0.33
-6.71
4.65
-11.79
25.93
Total Assets
974.96
979.44
925.39
677.59
571.72
461.08
413.18
333.59
327.56
361.91

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
10.22
74.66
23.60
-8.16
168.44
15.29
64.67
19.23
-12.53
7.48
PBT
-61.75
34.95
121.13
89.07
61.35
55.90
55.71
28.74
12.42
18.98
Adjustment
63.44
50.51
44.02
29.10
37.48
30.35
17.94
34.84
18.77
23.30
Changes in Working Capital
10.49
-5.91
-112.39
-103.32
87.83
-54.54
6.37
-37.69
-38.75
-32.19
Cash after chg. in Working capital
12.19
79.55
52.75
14.85
186.66
31.71
80.02
25.89
-7.55
10.08
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-1.97
-4.89
-29.15
-23.01
-18.22
-16.42
-15.35
-6.66
-4.98
-2.60
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-135.18
-112.51
-103.87
-73.11
-73.81
-52.50
-48.94
-17.70
-16.05
-19.22
Net Fixed Assets
-142.72
-114.72
-68.70
-136.14
-55.18
-48.32
-60.02
-7.11
79.50
-15.46
Net Investments
0.00
0.00
0.00
0.06
0.00
0.00
0.00
0.00
0.60
-0.04
Others
7.54
2.21
-35.17
62.97
-18.63
-4.18
11.08
-10.59
-96.15
-3.72
Cash from Financing Activity
124.96
37.77
80.48
81.34
-94.53
37.09
-18.25
-0.94
30.68
11.66
Net Cash Inflow / Outflow
0.00
-0.08
0.22
0.06
0.10
-0.12
-2.51
0.60
2.09
-0.08
Opening Cash & Equivalents
0.47
0.55
0.34
0.31
0.21
0.33
2.84
2.25
0.68
0.78
Closing Cash & Equivalent
0.47
0.47
0.55
0.34
0.31
0.21
0.33
2.84
2.25
0.70

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
188.13
213.72
202.17
157.63
125.66
103.16
86.42
70.36
60.28
69.56
ROA
-4.80%
2.69%
11.21%
10.42%
9.20%
8.18%
9.38%
5.80%
1.47%
4.57%
ROE
-11.90%
6.28%
25.50%
23.46%
21.24%
19.31%
22.90%
15.07%
4.01%
11.88%
ROCE
-4.50%
7.75%
22.21%
22.29%
20.44%
20.31%
23.75%
16.08%
10.65%
11.96%
Fixed Asset Turnover
0.85
1.31
1.72
1.91
2.14
2.32
2.70
2.73
1.61
1.46
Receivable days
128.71
123.89
123.70
113.66
98.14
103.75
115.06
111.38
136.14
99.91
Inventory Days
194.99
139.29
78.67
74.22
74.31
72.56
70.88
79.66
105.79
95.72
Payable days
152.31
166.93
150.04
176.37
112.38
80.55
94.02
100.09
137.14
112.44
Cash Conversion Cycle
171.39
96.26
52.33
11.51
60.07
95.76
91.92
90.96
104.80
83.18
Total Debt/Equity
1.34
0.81
0.71
0.61
0.40
0.87
0.74
0.92
1.08
0.69
Interest Cover
-1.45
2.69
14.37
19.75
5.87
5.52
6.23
3.35
1.97
1.98

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Astec Lifesciences - Quarterly Results
    25th Oct 2024, 18:21 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.